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ABSTRACT 
Background and Aims
To compare perioperative characteristics and outcomes between primary ileocolonic resection 
(PICR) and iterative ileocolonic resection (IICR) for Crohn’s disease.
Methods
From 2013 to 2015, 567 patients undergoing ileocolonic resection were prospectively included 
in 19 centers of the GETAID chirurgie group. Perioperative characteristics and postoperative 
results of both groups (431 PICR, 136 IICR) were compared. Uni- and multivariate analyses of 
the risk factors of overall 30-days postoperative morbidity was carried out in the IICR group.
Results
IICR patients were less likely to be malnourished (27.2% vs 39.9%, p=0.007), had more 
stricturing forms (69.1% vs 54.3% p=0.002) and less perforating disease (19.9% vs 39.2%, 
p<0.001). Laparoscopy was less commonly used in IICR (45.6% vs 84.5%, p<0.01) and 
associated with increased conversion rates (27.4% vs 14.6%, p=0.012). Overall postoperative 
morbidity was 36.8% in the IICR group and 26.7% in the PICR (p=0.024). There was no 
significant difference between IICR and PICR regarding septic intraabdominal complications, 
anastomotic leakage (8.8% vs 8.4%) and temporary stoma requirement. IICR patients more 
likely presented with non-infectious complications and ileus (11.8% vs 3.7%, p<0.001). Uni-
and multivariate analyses did not identify specific risk factors of overall postoperative 
morbidity in the IICR group. 
Conclusions
Surgery for recurrent CD is associated with a slight increase of non-infectious morbidity 
(postoperative ileus) that mainly reflects the technical difficulties of these procedures. 
However, iterative ileocolonic resection remains a safe therapeutic option in patient with 
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5
recurrent Crohn disease since severe morbidity including anastomotic complications is similar 
to patients undergoing primary resection. 
Keywords: Crohn’s disease; recurrent disease; ileo-colic resection; morbidity
No Funding to declare
Words: 2894
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INTRODUCTION
Despite increased use of immunosuppressive and anti-tumour necrosis factor (anti-TNF) 
treatments, approximately half of the patients presenting with Crohn’s Disease (CD) will 
require surgery within 10 years after diagnosis. 1 The main location of CD is terminal ileum 
with or without involvement of the proximal colon. Thus, up to 75% of patients requiring 
abdominal surgery for CD will have ileal or ileocolic resection (ICR), among which 20 to 40% 
are performed within the first year after the diagnosis. 2,3 Operative indications include failed 
medical therapy, complicated CD (perforation, obstruction, hemorrhage) and neoplasia, as 
expressed in the 2018 ECCO-ESCP guidelines. 4 In some specific indications, surgical resection 
has been proved to be an effective alternative to medical treatment. Indeed, Ponsioen et al. 
showed that laparoscopic resection in patients with limited (< 40 cm), non-stricturing ileocecal 
CD is a reasonable alternative to infliximab therapy in terms of health-related quality of life. 5 
However, surgical resection of the diseased bowel is not curative and postoperative recurrence 
remains a significant problem. 6 After ileocolic resection, endoscopic recurrence of CD arises 
in the neoterminal ileum in 30% of patients after 3 months and in up to 80% of patients after 1 
year. Clinical recurrence has been reported to be as high as 20-30% at 1 year with a 10% 
increase in each of the subsequent years. 7 The probability of a second resection for recurrent 
disease is 7-25% at 5 years and 19-35% at 10 years. 8,9 Data of the literature are scarce 
concerning surgery for recurrent CD after previous intestinal resection and are mainly based on 
retrospective data. In a comparative study, surgery for recurrent CD showed higher morbidity 
rate, greater risk of postoperative intra-abdominal abscess and longer postoperative hospital 
stay. 10 Comparing to primary ileocolic resections for CD, laparoscopy for iterative ileocolic 
resection has also been proved to be a safe and feasible approach without differences in stoma 
creation, early postoperative morbidity and mortality, reoperation rates and inhospital stay. 11-
14  However, no multicentric prospective study designed to specifically compare operative and 
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postoperative outcome between primary and iterative ileocolic resection for CD is currently 
available.
Thus, the aim of our study was to compare perioperative characteristics and outcomes between 
primary and iterative ileocolic resection in patients operated for ileocolic CD.
METHODS
Patients and data collection
This study was based on the previously published data of the GETAID chirurgie group cohort. 
15 Briefly, all patients undergoing surgery for ileocolic CD at 19 French academic centers were 
prospectively included from September 2013, to September 2015. To summarize, the inclusion 
criteria were: age >18 years, ileocolic CD and elective or emergency intestinal resection. The 
patients who had surgery for CD limited to a perianal or a colonic location were excluded. For 
the present work, we also excluded patients who underwent isolated stricturoplasty or small 
bowel resections. Variables including demographics, disease type and severity, previous 
treatment of CD, number and type of previous resections for CD, intraoperative findings and 
surgical procedures were prospectively collected. This study was conducted according to the 
ethical standards of the institutional committee on human experimentation and reported 
according to the Strengthening the Reporting of Observational Studies in Epidemiology 
(STROBE) guidelines. 16
Surgical procedure and postoperative outcome
The description of surgical procedures has been given in the previously published paper. 15 
Briefly, a laparoscopic approach was proposed as the favored option whenever possible at all 
participating centers. The bowel planned for resection was extracted through a 5 to 6 cm 
incision in a right lower quadrant or midline incision. Conversion to open surgery was defined 
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as any unplanned incision or a planned incision that was made longer than necessary to extract 
the resected specimen and fashion of the anastomosis. The decision to fashion primary 
anastomosis or temporary ileocolostomy was made on a per-patient basis and left to the 
discretion of the surgeon, according to the preoperative clinical data and intraoperative findings. 
The in-hospital or 30-day postoperative morbidity and mortality were recorded prospectively 
starting from the date of the surgery. Postoperative morbidity was defined as any deviation from 
the normal postoperative course, graded according to the Dindo-Clavien classification. 17 
Intraabdominal septic morbidity included anastomotic leakage with or without peritonitis, 
intraabdominal abscess and postoperative peritonitis. Moreover, the reoperation rate, length of 
hospital stay, and readmission ate were prospectively recorded. 
Statistical analysis
Patients were divided into two groups, namely “primary ileocolic resection” (PICR) and 
“iterative ileocolic resection” (IICR). The quantitative and qualitative variables were expressed 
as the mean ± the standard deviation (SD), median (interquartile range), and frequency. For 
univariate comparisons between the PICR and IICR groups, the chi-squared test was used for 
categorical variables, while the Mann–Whitney U test was applied for continuous variables. 
The primary endpoint was the overall 30-day postoperative morbidity. To identify the risk 
factors of the overall postoperative morbidity, univariate and multivariate analyses were used 
to examine the relationship between the occurrence of postoperative morbidity and 49 variables 
related to the patient characteristics and comorbidities, the type and severity of the CD, 
preoperative treatment targeting CD, preoperative biological parameters, and intraoperative 
findings and surgical procedures. Denutrition was defined as BMI<18 kg/m2, and/or weight 
loss> 10% of the body weight within 6 months before surgery and/or preoperative serum 
albumin <30 g/dL. The association of baseline parameters with postoperative morbidity was 
Page 9 of 23
https://mc.manuscriptcentral.com/ecco-jcc
Manuscripts submitted to Journal of Crohn's and Colitis
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Review Only
9
first assessed using univariable Cox analyses, and then parameters with P values of less than 
0.1 or clinically relevant variables known for their impact of postoperative morbidity were 
entered into a final multivariable Cox regression model.
A P value <0.05 was considered statistically significant. Statistics were performed using SPSS 
(Statistical Package for Social Science, IBM SPSS Statistics, Version 23 for Macintosh; IBM 
Corp., Armonk, NY, USA). 
RESULTS 
Preoperative characteristics and previous medical treatment (Table 1).
From September 1, 2013 to September 1, 2015, 567 patients underwent ICR. Four hundred and 
thirty-one underwent PICR (76%) and 136 (24%) underwent IICR. Denutrition was more 
frequent in the PICR group than in the IIRC group (39.9% vs. 27.2%, p=0.007). Thus, the 
proportion of patients receiving preoperative nutritional support was higher in the PICR group 
compared to the IICR patients (36.0% vs 25.7% respectively, p=0.028). The phenotype of CD 
according to Montreal/Vienna classification significantly differed between both groups 
(p<0.001). Indeed, perforating CD was more frequent in the PICR group (39.2% vs 19.9%) 
whereas stricturing CD was more frequent in the IICR group (69.1% vs 54.3%). Previous 
medical exposure within 6 and 3 months were similar in both groups. 
Surgical procedures and intraoperative findings (Table 2).
Laparoscopic approach was less frequently used in the IICR group (45.6% vs 84.5, p<0.01) and 
the conversion rate was significantly higher (27.4% vs. 14.6%, p=0.012). As expected, internal 
fistula (25% vs. 37.6%, p=0.007) and abscesses (11% vs. 20.2%, p=0.013) were less frequent 
in the IICR group. Primary anastomosis was performed in 449 patients (79.2%) with a majority 
of stapled ileocolic anastomosis (59.2%, n=266), without statistical difference between both 
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groups. Mean operative time was statistically longer in the IICR group (155.9 ± 53.3 min vs. 
138.9 ± 49.9 min, p=0.002). 
Postoperative outcome (Table 2).
Overall postoperative morbidity (36.8% vs. 26.7%, p=0.024), non-infectious morbidity (20.6% 
vs 13.7%, p=0.052) and ileus (11.8%. vs. 3.7%, p<0.001) were significantly higher in the IICR 
group. However, postoperative length of stay was similar between both groups (10.2±23.0 in 
the PICR vs. 9.3±6.9 days in the IICR, p=0.499). There were no significant differences between 
intraabdominal septic complications, anastomotic leakage rate, severe postoperative 
complications and reoperation with or without stoma confection between both groups (table 2).
Four hundred and forty-nine patients underwent ICR with primary anastomosis. 
We then compared postoperative outcomes in the subgroup with primary anastomosis between 
PICR (n=337, 75.1%) and IICR (n=112, 24.9%). Overall postoperative morbidity (38.4% vs. 
25.8%, p = 0.011) and non-infectious morbidity (21.4% vs. 11.9%, p=0.012) were significantly 
higher in the IICR group. There were no significant differences in infectious morbidity, surgical 
site infections, intraabdominal septic complications, anastomotic leakage, severe postoperative 
complications and reoperation rate for complications between both groups.
We also conducted a subgroup analysis on patients with elective procedures (PICR n=385 & 
IICR n=130). We found the same differences in patients’ characteristics. Laparoscopic 
approach was less frequently used for IICR (46.9% vs. 90.4%, p<0.001) with more conversions 
(27.9% vs. 13.8%, p=0.006). Again, overall morbidity was significantly increased in the IICR 
group (37.7% vs. 17.4%, p=0.015) but only the postoperative ileus was significantly increased 
in the IICR (11.5% vs. 2.4%, p<0.001).
Patients undergoing multiple IICR (Table 3).
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Primary anastomosis was performed in the vast majority of the patients (82.4%) and its rate 
was not correlated with the number of previous resections (p=0.578). Concerning the 
postoperative outcome, there was a tendency for more frequent intraabdominal septic 
complications in patients undergoing a third ICR or more (6.2% vs. 15.4%, p=0.087). Overall 
postoperative morbidity, severe complications, reoperation rate for complications and length of 
stay were not different depending on the number of previous ICR. 
Impact of case-volume on operative and postoperative outcomes (Table 4)
Mean ICR per center per year was 15.9 (±12.9), with 11.9 (±9.3) PICR per center per year and 
4.0 (±4.1) IICR per center per year. There were no significant differences in terms of 
laparoscopic approach (p=0.282), overall postoperative morbidity (p=0.829) and length of 
hospital stay (p=0.297) according to the yearly case-volume of the centers (Table 4). However, 
there was a trend toward a lower conversion rate in high volume centers (22.0% vs. 46.2%, 
p=0.080).
Analyses of the risk factors of overall postoperative morbidity (Table 5)
The results of the univariate and multivariate analyses of the risk factors for overall 
postoperative morbidity in 136 patients undergoing iterative ileocolic resection for ileocolic CD 
are reported in Table 5. In the univariate analysis, previous ICR (p=0.041) and intraoperative 
bowel injury (p=0.062) were associated with a higher risk of overall postoperative morbidity. 
However, none of these parameters were statistically significant in the multivariate analysis 
(p=0.138 and p=0.999 respectively).
DISCUSSION
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Our results confirm that surgery for recurrent CD slightly increases the risk of overall 
postoperative morbidity. This is explained by a more technically difficult procedure that usually 
lasts longer than primary surgery. This translates into a higher risk of non-infectious 
complications, especially ileus, whereas the risk of infectious complications and major 
morbidity is equivalent to primary surgery. Consequently, iterative ileocolonic resection 
remains a safe therapeutic option in patient with recurrent Crohn disease. However, although 
laparoscopy was feasible in 50% of the cases, IICR was technically more difficult. In this series, 
overall postoperative morbidity was increased in the IICR group but linked only to the 
postoperative ileus explained by the necessity of longer dissections and longer intraoperative 
durations. Indeed, the rate of AL and duration of hospitalization stay were similar in both 
groups.
In this prospective multicentric study, we included 136 IICR to 431 PICR within 3 years, 
which is, to our knowledge, the largest series in the literature. Only few previous studies focused 
on specific comparison between IICR and PICR. There were all retrospectives, unicentric with 
less than 80 patients undergoing iterative resections. 13,18,19 In their meta-analysis, Shigeta et al. 
evaluated the perioperative results of laparoscopy in 413 primary CD vs. 214 recurrent CD. 11  
More specifically, this last study involved 350 PICR and 164 IICR, mostly included 
retrospectively, in monocentric studies, over a period of 19 years, meanwhile our patients were 
prospectively included in a shorter range of time which limited more efficiently several biases.
The patients of the IICR group were less frequently malnourished, necessitated less 
preoperative nutritional support but had more favorable preoperative biological parameters 
(CRP<10 g/L). This better preoperative nutritional status may reflect a less aggressive behavior 
of the CD. Indeed, the patients of the IICR group presented more frequently a stricturing 
behavior of CD, whereas the patients of the PICR group presented with penetrating CD. 
Previous series comparing digestive resection surgery for primary vs recurrent CD were similar 
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to ours. Indeed, except for Manser et al. 19 stricturing behavior of CD was more frequent in 
recurrent CD and obstructive bowel syndrome was the main indication for surgery in this group. 
14,18,20,21 Stricturing behavior of CD has also been identified as an independent risk factor of 
surgical recurrence. 4 These differences reflect a better selection of patients before surgical 
resection and may explain the favorable results observed in this series.
The patients of the IICR group were older, with more patients > 65 years old. As in 
other studies, this difference is explained by a younger age at the diagnosis and a longer duration 
of the CD. 19,22 
As expert centers, the participating centers of this study performed laparoscopy as often 
as possible, according to the 2018 ECCO-ESCP recommendations. 4 In this study, laparoscopy 
was feasible in 45.6% of the IICR, which is comparable with the data of the literature. 10  
However, laparoscopy in IICR was technically more difficult than in PICR, as evidenced by 
the higher conversion rate and the prolonged operative duration than in the PICR group. 
Moreover, we showed that feasibility of a laparoscopic approach was also hampered with the 
number of previous resections. Other studies showed similar results, as Goyer et al. who showed 
that laparoscopy for complex and recurrent CD was associated with longer operative time and 
increased risk of conversion. 14 We did not have the data concerning the surgical approach of 
the first resection and therefore it was impossible to identify the probability of being operated 
through a laparoscopic approach after an open surgery.
Overall morbidity was significantly higher in the IICR group (36.8% vs. 26.7%, 
p=0.024). Studies comparing IICR vs. PICR showed similar results. 18 This higher morbidity 
rate was explained by a higher rate of postoperative ileus related to intraoperative adherences, 
longer dissections and thus longer operative duration and conversion rate. Our 3.7% rate of 
postoperative ileus in the PICR group was similar in the LIRIC trial (4%). 5 On the other hand, 
if the overall morbidity was increased in the IICR group due to ileus, it can be noted that specific 
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surgical morbidity and anastomotic leakage were not different in both groups, and this also in 
the subgroup of primary anastomoses. This increased postoperative ileus is of importance in 
the current management of such patients in whom the enhanced recovery programs will fail 
more frequently. 
Enhanced recovery for colorectal surgery (ERAS) programs is associated with shorter 
time to restoration of bowel movement and shorter length of hospital stay (LHS) in patients 
undergoing ICR for CD. 23,24 In our study, mean LHS was relatively long (9-10 days) but 
median was 7 days, similar in both group (PICR: 7 days (IQR=6-9), IICR : 7 days (IQR=6-10). 
Indeed, the 19 participating centers had diverse ERAS protocols with different inclusion 
criteria. However, data in the literature is in accordance with our findings.  In a RCT, Zhou and 
al. compared 16 laparoscopic PICR for CD with ERAS vs 16 PICR with conventional 
management for CD: mean postoperative DHS was 9.94 +/-3.3 days. 24 Brouquet and al. 
compared 57 PICR (52.6% through laparoscopic approach) with 54 IICR (48% through 
laparoscopic approach). 18 The median LHS was 7 days (4-18) versus 9 days (6-63) in the PICR 
and IICR group respectively. In the TRUE trial comparing single port versus conventional 
multiport conventional laparoscopy for colonic resection, including 47 (75%) conventional 
laparoscopic right colectomies for cancer, and 53 (42%) PICR for CD, the mean LHS was 6 
+/-2 days in the conventional laparoscopic group. 25Finally, in a randomized controlled trial, 
Maggiori and al. evaluated full vs limited ERAS programs in colorectal resections for cancer. 
26 Mean DHS was 9.4+/-3.3 days (range, 6-24) in the limited fast track program vs 8.6 +/- 3.5 
days in the full fast track program. Only Spinelli and al. , who evaluated ERAS programs in 
primary ileocolonic resections for CD found a shorter DHS of 6.8 +/-3.1 days in the patients 
undergoing laparoscopic primary ICR without ERAS. 23
In this series, we could not identify risk factors of postoperative overall morbidity in the 
IICR group and we did not demonstrate a negative impact of preoperative treatment targeting 
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CD as recently reported. 15 This could be related to a lack of statistical power. Indeed, only 29 
patients were treated previously with anti-TNF alpha in the IICR group which is insufficient to 
individualize an independent effect. Of this parameter, preoperative hemoglobin < 10g/dL was 
also not identified as a predictive factor of overall morbidity in our study. Indeed, patients in 
the IICR group were in a better general and nutritional condition, with a less inflammatory type 
of CD, which explains the low prevalence of anemia in this group. Operative duration > 180 
min was not individualized as a risk factor of postoperative morbidity. Indeed, the IICR group 
was characterized by longer operative duration. 
In conclusion, this large prospective multicentric study on IICR showed only an increase 
of post-operative ileus. Major surgical morbidity is similar to primary ileo-colic resection and 
iterative procedures should not push to creation of stoma and be performed in expert center 
through laparoscopy. This therapeutic option could thus be discussed in patients with recurrent 
disease and should not be denied on the basis of risk of increased morbidity.
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Table 1. Preoperative characteristics and previous medical treatments of patients undergoing 
IICR and PICR
Total
n=567
IICR
n=136
PICR
n=431
p
Age > 65 years 33 (5.8) 15 (11.0) 18 (4.2) 0.030
Male gender 247 (43.6) 57 (41.9) 190 (44.1) 0.656
BMI <18 92 (16.2) 17 (12.5) 75 (17.4) 0.164
BMI > 30 27 (4.8) 8 (5.9) 19 (4.4) 0.495
Denutrition 209 (36.9) 37 (27.2) 172 (39.9) 0.007
Current smoker 161 (28.4) 37 (27.2) 124 (28.8) 0.777
ASA score > 2 29 (5.1) 13 (9.6) 16 (3.7) 0.011
Duration of CD > 2 years 435 (76.7) 132 (97.1) 303 (70.3) <0.001
Previous acute episode > 3 80 (14.1) 28 (20.6) 52 (12.1) 0.013
Disease behavior
     Stricturing CD 328 (57.8) 94 (69.1) 234 (54.3)
     Inflammatory CD 43 (7.6) 15 (11.0) 28 (6.5)
     Perforating CD 196 (34.6) 27 (19.9) 169 (39.2)
<0.001
Multifocal intestinal CD 94 (16.6) 21 (15.4) 73 (16.9) 0.642
Associated colorectal CD 102 (18.0) 21 (15.4) 81 (18.8) 0.363
Associated perianal CD 82 (14.5) 24 (17.6) 58 (13.5) 0.221
Associated extradigestive CD 57 (10.1) 14 (10.3) 43 (10.0) 0.940
Previous isolated small bowel resection 127 (22.4) 103 (75.7) 24 (5.6) <0.001
Previous colorectal resection 63 (11.1) 54 (39.7) 9 (2.1) <0.001
Preoperative biologic parameters
     Hemoglobin level < 10 g/Dl 18 (3.2) 3 (2.2) 15 (3.5) 0.448
     Albumin serum level < 30 g/L 67 (15.5) 15 (11.0) 52 (12.1) 0.845
     C reactive protein serum level > 10 mg/L 240 (42.3) 45 (33.1) 195 (45.2) 0.028
Preoperative nutritional support 190 (33.5) 35 (25.7) 155 (36.0) 0.028
Previous medical treatment exposure 436(76.9) 105 (77.2) 331 (76.8) 0.950
     Steroids 59 (10.4) 12 (8.8) 47 (10.8) 0.488
     Thiopurin and/or Methotrexate 53 (9.3) 13 (9.6) 40 (9.3) 0.923
     All anti-TNF 146 (25.7) 31 (22.8) 115 (26.7) 0.411
Number of lines of medical treatment ≥ 2 190(33.5) 51 (37.5) 139 (32.3) 0.280
Medical treatment < 3 months before surgery 243 (42.9) 55 (40.4) 188 (43.6) 0.514
     Steroids 45 (7.9) 10 (7.4) 35 (8.1) 0.773
     Thiopurin and/or Methotrexate 47 (8.3) 10 (7.4) 37 (8.6) 0.650
     All anti-TNF 133 (23.5) 29 (21.3) 104 (30.9) 0.554
ASA American Society of Anesthesiologists, BMI body mass index, CD Crohn’s Disease, 
IICR: iterative ileocolonic resection, PICR: primary ileocolonic resection
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Table 2. Surgical procedures and postoperative outcome in patients undergoing IICR and 
PICR
Variables Totaln=567
IICR
n=136
PICR
n=431
p
Emergency surgery 52 (9.2) 6 (4.4) 46 (10.7) 0.027
Surgical approach
     Laparoscopy 426 (75.1) 62 (45.6) 364 (84.5) <0.001
     Conversion 70 (16.4) 17 (27.4) 53 (14.6) 0.012
Associated procedures 
     Strictureplasty 13 (2.3) 3 (2.2) 10 (2.3) 0.938
     Additional intestinal resection 40 (7.1) 9 (6.6) 31 (7.2) 0.819
Intraoperative findings
     Internal fistula 196 (34.6) 34 (25) 162 (37.6) 0.007
     Abscess 102 (18.0) 15 (11.0) 87 (20.2) 0.013
     Intraoperative CD length > 50 cm 61 (10.8) 5 (3.7) 56 (13.0) 0.002
Length of resected bowel > 50 cm 79 (13.9) 14 (10.3) 65 (15.1) 0.140
Intraoperative complication
     Bowel injury 2 (0.4) 2 (1.5) 0 -
     Bleeding 2 (0.4) 0 2 (0.5) -
Primary anastomosis 449 (79.2) 112 (82.4) 337 (78.2) 0.297
Type of anastomosis
     End to side
     End to end
     Side to side
86(15.2)
49(8.6)
304(53.6)
19 (14.0)
13 (9.6)
77 (56.6)
67 (19.9)
6 (10.7)
227 (67.4)
0.457
     Hand-sewn/stapled 183 (40.8) /266 (59.2) 38(33.9)/74(66.1) 145 (43)/192 (57) 0.100
Operative time, min 143.1 (+/- 51.2) 155.9 (+/- 53.3) 138.9 (+/-49.9) 0.002
Operative time > 180 min 121 (21.3) 42 (30.9) 79 (18.3) 0.002
Postoperative mortality 0 0 0 -
Overall postoperative morbidity 165 (29.1) 50 (36.8) 115 (26.7) 0.024
Infectious morbidity 101 (17.8) 27 (19.9) 74 (17.2) 0.476
Non infectious morbidity 87 (15.3) 28 (20.6) 59 (13.7) 0.052
Morbidity surgical site infection 78 (13.8) 19 (14.0) 59 (13.7) 0.934
Intraabdominal septic complications 48 (8.5) 12 (8.8) 36 (8.4) 0.863
     Anastomotic leakage with peritonitis 14/449 (3.1) 3/112 (2.7) 11/337 (3.3) 0.757
     Anastomotic leakage without peritonitis 11/449 (2.4) 2/112 (1.8) 9/337 (2.7) 0.600
     Intraabdominal abscess 23/567 (4.1) 7/136 (5.1) 16/436 (3.7) 0.460
Other complications
     Intraabdominal bleeding 12 (2.1) 1 (0.7) 11 (2.6) 0.199
     Ileus 32 (5.6) 16 (11. 8) 16 (3.7) <0.001
     Wound infection 22 (3.9) 8 (5.9) 14 (3.2) 0.165
     Urinary tract infection 11 (1.9) 4 (2.9) 7 (1.6) 0.332
     Pneumonia 2 (0.3) 0 2 -
     Pulmonary embolism 1 (0.2) 0 1 -
     Catheter infection 9 (1.6) 3 (2.2) 6 (1.4) 0.504
     Urinary retention 4 (0.7) 1 (0.7) 3 (0.7) 0.962
     Acute renal failure 6 (1.1) 0 6 (1.4) -
Severe complications (Dindo-Clavien III,IV) 49 (8.6) 11 (8.1) 38 (8.8) 0.792
Reoperation for complications 24 (4.2) 4 (2.9) 20 (4.6) 0.391
Reoperation with stoma for complications 19 (3.4) 4 (2.9) 15 (3.5) 0.761
Drainage for complications 14 (2.5) 2 (1.5) 12 (2.9) 0.389
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Length of stay mean±SD, median (IQR) 9.9±2.3; 7(6-9) 9.3±6.9; 7(6-10) 10.2±23.0); 7(6-9) 0.499
Table 3. Surgical procedures and post-operative outcomes in 136 patients undergoing iterative 
ileocolonic resection (IICR) depending on the number of previous ileocolonic resections
Iterative ICR
n = 136
2nd ICR
n = 97
3rd ICR or more
n = 39
p
Laparoscopy 62 (45.6) 48 (49.5) 14 (35.9) 0.150
Conversion 17 (27.4) 14 (14.4) 3 (7.7) 0.568
Primary anastomosis 112 (82.4) 81 (83.5) 31 (79.5) 0.578
Operative duration 155.9 (+/- 53.3) 153.2 (+/-52.4) 162.9 (+/-55.6) 0.747
Operative duration > 180 min 42 (30.9) 28 (28.9) 14 (35.9) 0.372
Overall postoperative morbidity 50 (36.8) 34 (35.1) 16 (41.0) 0.513
Intra-abdominal septic complications 12 (8.8) 6 (6.2) 6 (15.4) 0.087
Severe postoperative complications 11 (8.1) 7 (7.2) 4 (10.3) 0.557
Reoperation for complications 4 (2.9) 2 (2.1) 2 (5.1) 0.338
Length of stay mean±SD, median (IQR) 9.3±6.9; 7(6-10) 8.5±4.7; 7(6-9) 11.2±10.4; 7.5(6-13) 0.181
% are in parentheses
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Table 4. Operative and postoperative outcome by yearly case volume in the IICR group.
Volume ≤ 15 patients / year* Volume > 15 patients / year p
IICR/total 23/130 (17.7) 113/434 (26.0) 0.051
Laparoscopy 13/23 (56.5) 50/113 (44.2) 0.282
Conversion 6/13 (46.2) 11/50 (22.0) 0.080
Operative duration > 180 min 6/23 (26.1) 36/113 (31.9) 0.585
Overall postoperative morbidity 8/23 (34.8) 42/113 (37.2) 0.829
Length of stay mean±SD, median (IQR) 7.8±3.4; 7(4-8.5) 9.54±7.4; 7(6-10) 0.297
*One center of this group was excluded from this analysis because no IICR was performed 
(n=3 patients, among which 3 PICR and 0 IICR)
% are in parentheses
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Table 5. Univariate and multivariate analyses of risk factors of overall postoperative morbidity 
in 136 patients undergoing IICR.
Univariate analysis Multivariate analysis 
p p OR IC95%
Age > 65 years 0.770 0.848 0.926 0.229-3.747
Male gender 0.154 0.490 0.759 0.331-1.744
BMI <18 0.673 0.104 3.885 0.755-19.995
BMI > 30 0.955 -
Denutrition 0.298 0.225 0.429 0.107-1.722
Current smoker 0.768 0.627 1.249 0.481-3.245
ASA status > 2 0.279 0.230 0.401 0.090-1.783
Duration of CD > 2 years 0.122 -
Acute episode < 3 months 0.644 -
Previous acute episode > 3 0.103 -
Disease behavior
     Stricturing CD 0.347 -
     Inflammatory CD 0.770 -
     Perforating CD  0.680 0.547 0.718 0.257-2.009
Preoperative CD length > 50 cm 0.753 -
Multifocal intestinal CD 0.653 -
Associated colorectal CD 0.529 -
Associated perianal CD 0.325 -
Associated extra-digestive CD 0.209 -
Prior isolated small bowel resection 0.320 -
Prior colorectal resection 0.926 -
Number of previous ICR
     Second ICR vs. 3rd or more 0.513 0.470 1.254 0.493-3.191
Preoperative biologic parameters
     Hemoglobin level < 10 g/dL 0.247 -
     Albumin serum level < 30 g/L 0.168 -
     C reactive protein serum level > 10 mg/L 0.468 -
Preoperative nutritional support 0.724 -
Medical treatment < 3 months before surgery
     Steroids 0.127 0.999 - -
     Any anti-TNF 0.911 0.460 1.434 0.533-3.854
Intraoperative findings
     Internal fistula 0.347 -
     Abscess 0.752 -
Intraoperative CD length > 50 cm 0.242 -
Emergency surgery 0.296 -
Surgical approach
     Laparoscopy vs Laparotomy 0.667 -
     Conversion 0.734 -
Associated procedures 
     Strictureplasty 0.901 -
     Additional intestinal resection 0.349 -
Length of resected bowel > 50 cm 0.966 -
Primary anastomosis 0.395 -
Stapled vs handsewn anastomosis 0.678 -
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Operative time > 180 min 0.525 -
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